Drug development programs with significant therapeutic potential are often faced with challenges that may otherwise limit clinical success, including difficulties with drug solubility, pharmacokinetics, metabolism, bioavailability, biodistribution and immunogenicity.
Mersana combines proprietary drugs from new or existing therapeutic classes with the company’s custom conjugation technology, comprised of a Fleximer® polymer and a broad variety of linker chemistries, to engineer new drugs that overcome specific hurdles:
The end result of this strategy is a completely novel drug conjugate that is customized to overcome the specific obstacles in its path. This approach also provides intellectual property protection and extended patent life, via novel composition-of-matter.
Click on the image to view a video demonstrating